<DOC>
	<DOCNO>NCT00689585</DOCNO>
	<brief_summary>Pain remain debilitate symptom adult patient suffer complex regional pain syndrome ( CRPS ) . Most CRPS patient gain little relief current painkiller . The purpose study evaluate efficacy safety ethosuximide search much-needed adjunctive therapy relieve pain suffering associate CRPS .</brief_summary>
	<brief_title>Safety Efficacy Study Ethosuximide Treatment Complex Regional Pain Syndrome ( CRPS )</brief_title>
	<detailed_description>This single centre , parallel-group , double-blind , randomize , placebo-controlled pilot clinical trial adult suffer complex regional pain syndrome ( CRPS ) . Twelve ( 12 ) subject diagnose CRPS enrol randomize receive orally , either ethosuximide placebo . If maximum trial medication dosage ( 1500mg ) reach , subject study maximum 10 week screen ( Clinic Visit 1 ) end drug cessation period . The minimum period subject could complete study would 4 week presume previously disallow drug find 500mg dose tolerable .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Somatoform Disorders</mesh_term>
	<mesh_term>Complex Regional Pain Syndromes</mesh_term>
	<mesh_term>Reflex Sympathetic Dystrophy</mesh_term>
	<mesh_term>Ethosuximide</mesh_term>
	<criteria>Male female , age ≥18 year old ; Diagnosis Complex Regional Pain Syndrome ( CRPS ) use International Association Study Pain criterion &gt; 6 month ; Normal liver function ( AST level &lt; 3x normal level ) ; Normal kidney function ( serum creatinine &lt; 133µmol/L ) ; Full blood count , haematocrit &gt; 38 % ; Willing able give inform consent complete study questionnaire ; Stable ( change past two month ) suboptimal pain pharmacotherapy ( i.e . additional pain control felt patient physician necessary ) ; Able attend research centre accord visit schedule ; Women childbearing potential must use reliable form contraception i.e . oral contraceptive , barrier method ( condom diaphragm ) , intrauterine device abstinence . Optimal response opioids , antidepressant , anticonvulsant anti inflammatory medication ; Any history indication kidney liver disease ; Any history alcohol abuse ; Presence diabetes ; Subjects take antiepileptic drug , include gabapentin , pregabalin , topiramate , phenytoin , carbamazepine , oxcarbazepine ; Pregnancy ( serum bHCG pregnancy test perform part initial blood panel ) ; Known suspect allergy succinimides , ethosuximide , methsuximide ( Celontin® ) , phensuximide ; Any history mental illness disorder , investigator opinion , interfere subject ability accurately report treatment response ; Participation clinical trial 30 day prior enrolment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Complex Regional Pain Syndrome</keyword>
	<keyword>Reflex Sympathetic Dystrophy</keyword>
	<keyword>RSD</keyword>
	<keyword>Chronic Pain</keyword>
	<keyword>Ethosuximide</keyword>
	<keyword>Zarontin</keyword>
	<keyword>Anticonvulsant</keyword>
</DOC>